Parameter | Description |
B | Birth rate |
ρ | Rate of recovery from infection |
η | Rate of infected individuals |
π | Natural death rate |
Ω | Infected rate |
ω | Measles therapy rate |
WW domain-containing transcription regulator 1 (TAZ, or WWTR1) and Yes-associated protein 1 (YAP) are both important effectors of the Hippo pathway and exhibit different functions. However, few studies have explored their co-regulatory mechanisms in kidney renal clear cell carcinoma (KIRC). Here, we used bioinformatics approaches to evaluate the co-regulatory roles of TAZ/YAP and screen novel biomarkers in KIRC. GSE121689 and GSE146354 were downloaded from the GEO. The limma was applied to identify the differential expression genes (DEGs) and the Venn diagram was utilized to screen co-expressed DEGs. Co-expressed DEGs obtained the corresponding pathways through GO and KEGG analysis. The protein-protein interaction (PPI) network was constructed using STRING. The hub genes were selected applying MCODE and CytoHubba. GSEA was further applied to identify the hub gene-related signaling pathways. The expression, survival, receiver operating character (ROC), and immune infiltration of the hub genes were analyzed by HPA, UALCAN, GEPIA, pROC, and TIMER. A total of 51 DEGs were co-expressed in the two datasets. The KEGG results showed that the enriched pathways were concentrated in the TGF-β signaling pathway and endocytosis. In the PPI network, the hub genes (STAU2, AGO2, FMR1) were identified by the MCODE and CytoHubba. The GSEA results revealed that the hub genes were correlated with the signaling pathways of metabolism and immunomodulation. We found that STAU2 and FMR1 were weakly expressed in tumors and were negatively associated with the tumor stages. The overall survival (OS) and disease-free survival (DFS) rate of the high-expressed group of FMR1 was greater than that of the low-expressed group. The ROC result exhibited that FMR1 had certainly a predictive ability. The TIMER results indicated that FMR1 was positively correlated to immune cell infiltration. The abovementioned results indicated that TAZ/YAP was involved in the TGF-β signaling pathway and endocytosis. FMR1 possibly served as an immune-related novel prognostic gene in KIRC.
Citation: Sufang Wu, Hua He, Jingjing Huang, Shiyao Jiang, Xiyun Deng, Jun Huang, Yuanbing Chen, Yiqun Jiang. FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP[J]. Mathematical Biosciences and Engineering, 2022, 19(9): 9295-9320. doi: 10.3934/mbe.2022432
[1] | Pooja Yadav, Shah Jahan, Kottakkaran Sooppy Nisar . Analysis of fractal-fractional Alzheimer's disease mathematical model in sense of Caputo derivative. AIMS Public Health, 2024, 11(2): 399-419. doi: 10.3934/publichealth.2024020 |
[2] | Muhammad Farman, Muhammad Azeem, M. O. Ahmad . Analysis of COVID-19 epidemic model with sumudu transform. AIMS Public Health, 2022, 9(2): 316-330. doi: 10.3934/publichealth.2022022 |
[3] | Kottakkaran Sooppy Nisar, Muhammad Wajahat Anjum, Muhammad Asif Zahoor Raja, Muhammad Shoaib . Recurrent neural network for the dynamics of Zika virus spreading. AIMS Public Health, 2024, 11(2): 432-458. doi: 10.3934/publichealth.2024022 |
[4] | Maryam Batool, Muhammad Farman, Aqeel Ahmad, Kottakkaran Sooppy Nisar . Mathematical study of polycystic ovarian syndrome disease including medication treatment mechanism for infertility in women. AIMS Public Health, 2024, 11(1): 19-35. doi: 10.3934/publichealth.2024002 |
[5] | Musyoka Kinyili, Justin B Munyakazi, Abdulaziz YA Mukhtar . Mathematical modeling and impact analysis of the use of COVID Alert SA app. AIMS Public Health, 2022, 9(1): 106-128. doi: 10.3934/publichealth.2022009 |
[6] | Ahmed A Mohsen, Hassan Fadhil AL-Husseiny, Xueyong Zhou, Khalid Hattaf . Global stability of COVID-19 model involving the quarantine strategy and media coverage effects. AIMS Public Health, 2020, 7(3): 587-605. doi: 10.3934/publichealth.2020047 |
[7] | S. J. Olshansky, L. Hayflick . The Role of the WI-38 Cell Strain in Saving Lives and Reducing Morbidity. AIMS Public Health, 2017, 4(2): 127-138. doi: 10.3934/publichealth.2017.2.127 |
[8] | David V. McQueen, Erma Manoncourt, Yuri N. Cartier, Irina Dinca, Ülla-Karin Nurm . The Transferability of Health Promotion and Education Approaches Between Non-communicable Diseases and Communicable Diseases—an Analysis of Evidence. AIMS Public Health, 2014, 1(4): 182-198. doi: 10.3934/publichealth.2014.4.182 |
[9] | Mehreen Tariq, Margaret Haworth-Brockman, Seyed M Moghadas . Ten years of Pan-InfORM: modelling research for public health in Canada. AIMS Public Health, 2021, 8(2): 265-274. doi: 10.3934/publichealth.2021020 |
[10] | Ali Moussaoui, El Hadi Zerga . Transmission dynamics of COVID-19 in Algeria: The impact of physical distancing and face masks. AIMS Public Health, 2020, 7(4): 816-827. doi: 10.3934/publichealth.2020063 |
WW domain-containing transcription regulator 1 (TAZ, or WWTR1) and Yes-associated protein 1 (YAP) are both important effectors of the Hippo pathway and exhibit different functions. However, few studies have explored their co-regulatory mechanisms in kidney renal clear cell carcinoma (KIRC). Here, we used bioinformatics approaches to evaluate the co-regulatory roles of TAZ/YAP and screen novel biomarkers in KIRC. GSE121689 and GSE146354 were downloaded from the GEO. The limma was applied to identify the differential expression genes (DEGs) and the Venn diagram was utilized to screen co-expressed DEGs. Co-expressed DEGs obtained the corresponding pathways through GO and KEGG analysis. The protein-protein interaction (PPI) network was constructed using STRING. The hub genes were selected applying MCODE and CytoHubba. GSEA was further applied to identify the hub gene-related signaling pathways. The expression, survival, receiver operating character (ROC), and immune infiltration of the hub genes were analyzed by HPA, UALCAN, GEPIA, pROC, and TIMER. A total of 51 DEGs were co-expressed in the two datasets. The KEGG results showed that the enriched pathways were concentrated in the TGF-β signaling pathway and endocytosis. In the PPI network, the hub genes (STAU2, AGO2, FMR1) were identified by the MCODE and CytoHubba. The GSEA results revealed that the hub genes were correlated with the signaling pathways of metabolism and immunomodulation. We found that STAU2 and FMR1 were weakly expressed in tumors and were negatively associated with the tumor stages. The overall survival (OS) and disease-free survival (DFS) rate of the high-expressed group of FMR1 was greater than that of the low-expressed group. The ROC result exhibited that FMR1 had certainly a predictive ability. The TIMER results indicated that FMR1 was positively correlated to immune cell infiltration. The abovementioned results indicated that TAZ/YAP was involved in the TGF-β signaling pathway and endocytosis. FMR1 possibly served as an immune-related novel prognostic gene in KIRC.
Mathematical epidemiology is the use of mathematical models and methodologies to gain insights into the transmission and behavior of contagious diseases among populations. This discipline holds a crucial place in epidemiological investigations and contributes to the formulation of public health strategies. These mathematical models simulate disease transmission, predict outbreaks, assess the impact of interventions (such as vaccination campaigns or social distancing measures), and evaluate the effectiveness of various control strategies. We refer to [1]–[4]. These models incorporate variables such as population size, disease transmission rates, incubation periods, and other epidemiological parameters, giving important information on how infectious illnesses behave and directing public health initiatives. Mathematical modeling has proven to be valuable in the investigation and control of diseases like COVID-19, TB virus, influenza and Ebola disease, waterborne disease, hepatitis B virus and rabies virus, etc. For the mentioned diseases which have been studied by using mathematical models, we refer to [5]–[7].
Fractional calculus (FC) distinguishes itself from classical differential and integral calculus in how it applies integral and differential operators. Fractional order differential equations (FODEs) have been crucial in efforts to improve our understanding of many diseases, resulting in the development and investigation of mathematical models for a variety of diseases [8]. The use of FC has increased its value as a useful research tool in a number of fields across various domains in the realms of basic sciences and engineering. One key feature of fractional derivatives is their ability to manage integrals and derivatives of any order, regardless of whether they are real or complex. This unique property gives them a nonlocal quality, meaning that the future condition depends not just on the present state but also on all past states. Within the framework of FC, three distinct types of fractional differential operators exist. The Riemann-Liouville (RL) and Caputo relies on the power-law kernel [9]. The Caputo-Fabrizio derivative is rooted in decay processes [10], [11]. Finally, the Mittag-Leffler law encompasses both the power law and exponential decay. These properties can be effectively described by using Atangana–Baleanu fractional-order derivatives. These remarkable characteristics have been utilized in various fields, encompassing mathematics, applied sciences, engineering, biology and physics [12]. Authors [13] derived and simulated the numerical solutions for several control techniques in different fractional orders by using the iterative fractional-order Adams-Bashforth methodology. Researchers have made significant attempts to investigate this specific topic, exploring it from many perspectives which include both theoretical and numerical investigations. They developed an extensive number of methodologies and processes, each specifically to provide theoretical, analytical, and numerical results such as unraveling pine wilt disease by using a spectral method [14], the transmission dynamics and sensitivity analysis of pine wilt disease through the use of a fractal fractional operator [15], the sensitivity analysis of COVID-19 [16], the development of a fractional order model with non-local kernels [17], the fractional mathematical modeling of malaria disease and typhoid fever disease [18], [19], analysis and optimal control of SEIRI epidmic model [20]. Also, the numerical solution of the nonlinear delay integrodifferential equation using a wavelet [21], the variable-order fractional differential equation using Haar wavelet [22], Ulam- type stability of the impulsive delay integrodifferential equation [23] the computational modeling of a measles epidemic in human population [24], the co-dynamics of measles and dysentery disease [25], and the modeling of childhood disease outbreak in a community with the inflow of susceptible and vaccinated new-born [26]. These approaches have proven to be quite useful in the study of a wide range of problems, including difficulties relating to existence, approximation, and stability theory, among others [27]. Solving fractional differential equations (FDEs) to obtain accurate or analytical solutions can be time-consuming. In response to this difficulty, numerous tools and methodologies have arisen in recent decades to handle this topic and achieve approximations or analytical results. Techniques such as the decomposition method [28], transform method, and perturbation method [29] are examples of analytical and semi-analytical procedures. Numerical approaches have been created to identify approximate solutions to various FDEs problems. Spectral methods [30] are examples of notable numerical techniques.
Wavelet analysis has become a popular topic of research in several scientific and technical domains. Wavelets are viewed as a fresh basis for functions by a number of scholars and as a tool for time-frequency analysis by others. Given that wavelets are a flexible tool with many mathematical components and several potential uses, it is obvious that all of these are accurate [31], [32]. By using wavelet techniques, we can break down a complicated function into several smaller ones and study each one separately at various scales. This feature, along with a fast wavelet approach, makes these methods very interesting for analysis and synthesis. Wavelet-based collocation techniques have become more popular in numerical analysis because of their fast convergence, low computational cost, and straightforward procedure [33]. Wavelet techniques are a relatively recent addition to the family of orthogonal functions, with notable and attractive properties such as orthogonality, compact support, unconstrained regularity and good localization. As a result, they are frequently used to derive the numerical solutions to several mathematical models that are being developed in the fields of biology, chemistry, and physical sciences. Various types of wavelets, such as Chebeshev [34], the Haar method [35], etc. Hermite technique were used by researchers [36] to compute numerical solutions to infectious disease model. Authors [37] applied Bernstein wavelets to study a biological model. These wavelet-based approaches not only possess a strong mathematical foundation that also exhibit the capability to tackle nonlinear problems effectively. Among the various types of wavelets, Haar wavelets hold a distinct place. They are characterized by a pairwise constant function that forms the Haar wavelet basis series, making them one of the simplest wavelet series in mathematics. The Haar wavelet's orthogonality, local support, and simplicity make it an effective choice for use in the derivation of the numerical solution of FODEs. Recently, the Haar wavelets approach has been used to solve the HIV infection fractional model [38], the SEIR epidemic model [39]. The ability of Haar wavelets to efficiently capture complex nonlinear dynamics while maintaining high accuracy makes them particularly well-suited for handling the intricacies of fractional-order models. Moreover, the robustness of Haar wavelet methods when dealing with nonlinearities, coupled with their computational speed, significantly contributes to efforts to model the dynamic nature of measles disease. Given the inherently nonlinear nature of epidemiological systems and the fractional-order dynamics involved in measles transmission, researchers may improve the efficacy of measles dynamics simulations and analyses by making use of Haar wavelet approaches, which not only minimize computer cost they also increase model correctness and dependability. Due to the advantages offered by Haar wavelets when applied to solve the nonlinear models of fractional order, we are motivated to use the Haar wavelet collocation method (HWCM) to address the nonlinear fractional model of measles disease. The aim was to analyze the dynamics of the system with the utmost precision and minimal error. This work's major goal was to present and explore an HWCM that uses the Haar wavelet basis to understand the numerical and geometrical behavior of a nonlinear mathematical model. The findings in this research are original and have not previously been reported in the literature. This technique eliminates complex numerical methods and yields valuable insights into the numerical behavior of the model. The proposed solution also uses numerical computing to tackle the problem. Researchers have also used other numerical and analytical techniques to study various biological models, we refer to [40]–[42]. Also researchers have deduced various results devoted to mathematical analysis including the existence theory, and Ulam-Hyers stability criteria which have now a days extended to mathematical problems of physical importance. For mentioned results, we refer to [43]–[46].
In several infectious diseases, there is an initial latent period following exposure corresponding to the period before individuals become infectious. This latent period is a crucial aspect of disease progression and cannot be overlooked when analyzing infectious stages. Consequently, it is sensible to incorporate an initial compartment into epidemiological models. We have created a clear and predictable mathematical model to explain the process of measles transmission. In order to construct the model, the entire population (N) is segmented into four distinct categories: susceptible (S), exposed (E), infected (I), and recovered (R). In Figure 1, we have detailed the changes that occurred between these groups. The susceptible class, denoted as (S), experiences an increase due to births or immigration at a rate represented by B. At a rate π, natural death also has an impact. At a rate η, infection results from contact with infected people. At a rate η, interaction with infected individuals results in the generation of a class E, which is the group of exposed individuals. This class decreases as a results of testing and treatment for measles at a rate of ω, transitioning to the infected class at a rate of Ω. In addition to these factors, the population in this class is also influenced by the natural mortality rate denoted as π. The group of infected people, denoted as class I, emerges as a result of the transition of exposed peoples at a rate of Ω. It is decreased at a rate of ρ through infection recovery and at a rate of π due to natural mortality. The model requires the assumption that both recovered exposed persons and recovered infected persons develop a lifelong immunity to the illness. As a result, a class R is created, which is made up of those who have total immunity to the illness. Natural mortality affects this class of recovered people at a rate of π [40], [41].
Parameter | Description |
B | Birth rate |
ρ | Rate of recovery from infection |
η | Rate of infected individuals |
π | Natural death rate |
Ω | Infected rate |
ω | Measles therapy rate |
Consequently, the deterministic model's diagram is as shown in Figure 1.
The following forms are used to present the fractional order SEIR model [27], [40], [42].
dS(τ)dτ=B−ηS(τ)I(τ)−πS(τ),dE(τ)dτ=ηS(τ)I(τ)−(ω+π+Ω)I(τ),dI(τ)dτ=ΩE(τ)−(ρ+π)I(τ),dR(τ)dτ=ρI(τ)+ωE(τ)−πR(τ). | (1.1) |
N(τ)=S(τ)+E(τ)+I(τ)+R(τ),∀τ. According to (1.1), (S+E+I+R)′=0; thus, N(τ) is constant and equal to N. System (1.1) is in a feasible region because Δ={(S+E+I+R):0≤S,E,I,R≤N}. All associated parameters and state variables in the model stay non-negative while it follows the human population, where τ≥0.
The remaining sections of this article are structured as follows. Section 2 discusses the preliminaries and fractional model formulation. Section 3 elaborates on the theoretical properties associated with the fractional model and qualitative analysis. In Section 4, we establish essential conditions for the Ulam-Hyers stability (UHS) of the solution within the context of the model under consideration. Section 5 presents the numerical scheme, along with graphical results and a corresponding discussion. Lastly, in Section 6, the conclusion is drawn.
Fractional-order models have garnered a significant amount of attention across various scientific disciplines and have been the focus of extensive research. Our exploration begins with the concepts of fractional-order integration and differentiation, as described in [9], [10]. We provide a brief overview of key lemmas and definitions from FC that are essential for studying the proposed model.
Definition 2.1. [1] For any function Θ∈L1([0,∞),R) the RL integral with order χ∈(0,1) is given by
Definition 2.2. [1] For any function Θ the fractional order χ Caputo derivatives is defined as follows:
Definition 2.3. The subsequent equation holds true:
Ia[cDχΘ](τ)=Θ(τ)+b0+b1τ+b2τ2+…+bn−1τn−1, |
where
Lemma 2.4. Given g as a compact and continuous mapping from the Banach space B → D, where B is characterized by elements X∈B such that X=ΥgX with Υ in the interval [0, 1], when D is bounded, it implies that for the function g there exists at least one fixed point.
Haar wavelet function H(τ), along with its corresponding Haar scaling function denoted by ˜H0(τ) defined as:
H(τ)={1,τ∈[0,12),−1,τ∈[12,1),0,otherwise, |
ifτ∈[0,1),˜H0(τ)=1. |
On [0, 1), multi-resolution analysis produces a range of Haar wavelets, each of which can be represented as ˜Hm(τ) [34]. As a result, this leads to the subsequent relationship:
˜Hs(t)=2j/2H(2jτ−p),s=1,2,…, |
where
˜Hv,s(τ)=˜Hs(τ+1−v),for v=1,2,…, ρ,s=0,1,2,…, where ρ∈N. |
From [34] we conclude that the sequence ⟨˜Hs(τ)⟩∞s=0 constitutes a comprehensive orthonormal system within the space
⟨˜Hv,s(τ)⟩∞s=0, v=1,2,…,ρ, |
is orthonormal in
g(τ)=∑ρv=1∑∞s=0Cv,s˜Hv,s(τ). |
Moreover, when this series is truncated, we obtain an approximate equivalent, denoted as
g(τ)≈yq(τ)=∑ρv=1∑q−1s=0cv,s˜Hv,s(τ)=BTρq×1˜Hρq×1(τ), |
Here, the coefficients denoted by
⟨g(τ),˜Hv,s(τ)⟩=∫vv−1g(τ)˜Hv,s(τ)dτ, |
BTρq×1=[C1,0,…,C1,p−1,C2,0,…,C2,p−1,…,Cρ,0,…,Cρ,q−1] |
˜HTρq×1=[˜H1,0,…,˜H1,p−1,˜H2,0,…,˜H2,p−1,…,˜Hρ,0,…,˜Hρ,q−1] |
and the superscript T indicates the transpose of a matrix.
Temporal memory effects are a common feature of biological processes, and particularly epidemiological dynamics, and they provide important new insights into nonlocal dynamics. Fractional derivatives provide a more efficient way to solve these difficult problems since time-varying kernels are intrinsic to non-integer order derivatives. Fractional derivatives appear in diverse forms in the literature, with the Caputo fractional derivative emerging as the most frequently encountered form. The Caputo operator offers a distinct benefit, as it does not require fractional initial values, unlike classical derivatives. Given these advantageous characteristics, we have opted to employ the Caputo operator in our computational model (1.1).
We add a time-varying kernel in the way described below in order to achieve the power correlation:
In integral form, the system (1.1) may be expressed as follows:
dS(τ)dτ=∫ττ0K(τ−θ)[B−ηS(τ)I(τ)−πS(τ)] dθ,dE(τ)dτ=∫ττ0K(τ−θ)[ηS(τ)I(τ)−(ω+π+Ω)I(τ)] dθ,dI(τ)dτ=∫ττ0K(τ−θ)[ΩE(τ)−(ρ+π)I(τ)] dθ,dR(τ)dτ=∫ττ0K(τ−θ)[ρI(τ)+ωE(τ)−πR(τ)] dθ. | (2.2) |
By inserting the
CDχ−1τ(dS(τ)dτ)=CDχ−1τI−(χ−1)(B−ηS(τ)I(τ)−πS(τ)),CDχ−1τ(dE(τ)dτ)=CDχ−1τI−(χ−1)(ηS(τ)I(τ)−(ω+π+Ω)I(τ)),CDχ−1τ(dI(τ)dτ)=CDχ−1τI−(χ−1)(ΩE(τ)−(ρ+π)I(τ)),CDχ−1τ(dR(τ)dτ)=CDχ−1τI−(χ−1)(ρI(τ)+ωE(τ)−πR(τ)). |
Next, The operators CDχ−1τ and I−(χ−1) exhibit an interesting property they mutually cancel each other out. Further, to keep the dimension balance on both sides, we re-write the model as follows:
CDχτS(τ)=Bχ−ηχS(τ)I(τ)−πχS(τ),CDχτE(τ)=ηχS(τ)I(τ)−(ωχ+πχ+Ωχ)I(τ),CDχτI(τ)=ΩχE(τ)−(ρχ+πχ)I(τ),CDχτR(τ)=ρχI(τ)+ωχE(τ)−πχR(τ). | (2.3) |
Here, the basic reproductive number for the model (2.3) is given as follows:
The sensitivity index can be computed as follows [19]:
SR0p=pR0∂R0∂p, | (2.5) |
where p represents a parameter of expression (2.4). Using 2.5, we can compute the sensitivity index as follows:
SR0η=1>0, SR0β=1>0, SR0π=−1.437<0,SR0ω=−0.543<0, SR0Ω=−0.0217<0. |
We present the sensitivity index graphically in figure 2 as follows:
We evaluate the suggested model's well-posedness in this section [43], [44]. To achieve this, we employ methods from fixed-point theory to examine the solutions for the proposed system. The expression on the left-hand side of equation (1.1) assumes the following structure:
X1(τ,S,E,I,R)=Bχ−ηχS(τ)I(τ)−πχS(τ),X2(τ,S,E,I,R)=ηχS(τ)I(τ)−(ωχ+πχ+Ωχ)I(τ),X3(τ,S,E,I,R)=ΩχE(τ)−(ρχ+πχ)I(τ),X4(τ,S,E,I,R)=ρχI(τ)+ωχE(τ)−πχR(τ). | (3.1) |
This allows us to systematically assess the model's solution stability and characteristics through well-established mathematical methods. Let the Banach space ξ=C([0,T]×R4,R), and 0≤τ≤T<∞; then,
‖W‖ξ=supτ∈[0,T](|S(τ)|+|E(τ)|+|I(τ)|+|R(τ)|), |
W(τ)=(S(τ)E(τ)I(τ)R(τ)),W0=(S0E0I0R0),X(τ,W(τ))=(X1(τ,S,E,I,R)X2(τ,S,E,I,R)X3(τ,S,E,I,R)X4(τ,S,E,I,R))(τ). |
From (3.1), the proposed system (1.1) can takes the following form:
cDχW(τ)=X(τ,W(τ)),τ∈[0,T], | (3.2) |
where
The Caputo initial value problem (3.1) along with definition (2.3) give
W(τ)=W0+∫τ0(τ−s)χ−1Γ(χ)X(s,W(s))ds,τ∈[0,T]. | (3.3) |
We rely on the following assumptions to demonstrate the existence of the (1.1):
(H1): ∃ positive constants QX and ΨX as ∀ M∈ξ:
‖X(τ,W(τ))‖≤QX‖W‖+ΨX. |
(H2): ∃ a positive constant ΨX as ∀ W,W′∈ξ:
‖X(τ,W)−X(τ,W′)‖≤χX‖W−W′‖. |
Theorem 3.1. [32] Assume that the conditions in (H1) hold and X:[0,T]×R4→R is a continous mapping then there is at least one solution for equation (3.3). As a result, at least one solution exists for (1.1) with vQX<1, where v=TχΓ(χ+1).
Proof. Assuming that (H1) is satisfied, for τ∈[0,T], we define:
L={W(τ)∈ξ:‖W‖ξ≤ζ}, |
as a closed subset of ξ with convex properties, where ζ≥v0+vΨX1−vQX. Further, define
as
TW(τ)=W0+1Γ(χ)∫τ0(τ−s)χ−1X(s,W(s))ds. |
Assume that
|TW(τ)|=|W0+1Γ(χ)∫τ0(τ−s)χ−1X(s,W(s))ds|,≤|W0|+1Γ(χ)∫τ0(τ−s)χ−1|X(s,W(s))|ds,≤v0+vQXζ+vΨX,≤ζ. |
This implies that ‖TW(τ)‖χ≤ζ; hence, T(L)⊂L.
We examine
‖TW(τ2)−TW(τ1)‖=|(W0+∫τ20(τ2−s)χ−1Γ(χ)X(s,W(s))ds)−(W0+∫τ10(τ1−s)χ−1Γ(χ)X(s,W(s))ds)|,=|[∫τ20(τ2−s)χ−1Γ(χ)−∫τ10(τ1−s)χ−1Γ(χ)]X(s,W(s))ds|, |
and so
‖TW(τ2)−TW(τ1)‖≤(QXζ+vΨX)Γ(χ+1)|τχ−12−τχ−11|. | (3.4) |
Now, the right-hand side of (3.4) approaches 0, as τ2 approaches τ1. Therefore, ‖TW(τ2)−TW(τ1)‖ξ→0; clearly, T is uniformly continuous and bounded.
As a result T is completely continuous according to the Arzela–Ascoli theorem. Consequently, utilizing Schauder's fixed-point theorem, (1.1) possesses at least one solution. □
Theorem 3.2. Assuming that (H2) is valid and TχΨX<Γ(χ+1), the measles model (1.1) possesses a singular, unique solution.
Proof. Let W and W′ be two solutions in ξ, and consider
‖TW−TW′‖ξ=maxτ∈[0,T]|∫τ01Γ(χ)(τ−s)χ−1X(s,W(s))ds−∫τ01Γ(χ)(τ−s)χ−1X(s,W(s))ds|,≤∫τ0(τ−s)χ−1Γ(χ)|X(s,W(s))−X(s,W′(s))|ds,≤maxτ∈[0,T]∫τ0(τ−s)χ−1Γ(χ)ΨX‖W−W′‖ξds,≤TχΓ(χ+1)ΨX‖W−W′‖ξ. |
The operator T exhibits continuity, and consequently, the Banach principle ensures the uniqueness of the solution to (1.1). □
To conduct a comprehensive stability analysis of the proposed model, we revisit several definitions [45]. Consider
We will say that equation (4.1) exhibits Ulam-Hyers stability if, for every E>0 and
‖¯W−W‖ξ≤gqE. | (4.2) |
Furthermore, there exists at most one solution W of (4.1) with
‖¯W−W‖ξ≤gqE. | (4.3) |
Definition 4.1. [?] If, for all W∈C(R) satisfying that
‖¯W−W‖c≤W(E), |
then (4.1) exhibits generalized UHS.
Remark 4.2. [?] Let Z(τ)∈C([0,T];R), where
(i) |Z(τ)|≤E,
(ii)
For our analysis, we examine the perturbed initial value problem denoted in (3.2), i.e.,
cDχ+0W(τ)=W(τ,W(τ))+Z(τ), | (4.4) |
with the initial condition
Lemma 4.3. [32]. The below inequality satisfies (4.4):
‖W−TW‖≤aE, |
where
a=TχΓ(χ+1). |
Theorem 4.4. [46] From Lemma 4.3, the solution to equation (3.2) exhibits UHS when
Proof. Consider an arbitrary solution
‖W(τ)−¯W(τ)‖ξ=‖W(τ)−T¯W(τ)‖ξ≤‖W(τ)−TW(τ)‖ξ+‖TW(τ)−T¯W(τ)‖ξ≤aE+TχLpΓ(χ+1)‖W(τ)−¯W(τ)‖ξ, |
we conclude that
‖W−¯W‖ξ≤aE1−TχLpΓ(χ+1). |
Demonstrating the UHS of (3.2) also yields the generalized derivation of the UHS. □
Definition 4.5. Consider (4.1) to demonstrate the stability in the sense of Ulam-Hyers-Rassias for a function W∈C([0,T],R) for any given E>0, with W∈ξ as a solution of
‖W−TW‖ξ≤W(τ)E,for τ∈[0,T], | (4.5) |
there exists a solution W of (4.1) with
‖¯W−W‖c≤gqW(τ)E. |
Definition 4.6. For W∈C([0,T],R), assume the existence of a constant
‖¯W−W‖ξ≤Cq,WW(τ), |
So (4.1) is generalized Ulam–Hyers–Rassias stable.
Lemma 4.7. The following inequality holds true for (4.3):
‖W(τ)−TW(τ)‖≤aE, |
such that
a=TχΓ(χ+1). |
Lemma 4.8. [?] According to Lemma (4.7), the solution of (4.3) has UHS and generalized UHS whenever TχLpΓ(χ+1)<1.
Proof. Consider an arbitrary solution,
‖W(τ)−¯W(τ)‖ξ=‖W(τ)−T¯W(τ)‖ξ,≤‖W(τ)−TW(τ)‖χ+‖TW(τ)−T¯W(τ)‖ξ,≤aW(τ)E+TχLpΓ(χ+1)‖W(τ)−¯W(τ)‖ξ. |
This gives
‖W(τ)−¯W(τ)‖ξ≤aW(τ)E1−TχLpΓ(χ+1). |
As a result, (3.2) exhibits UHS, making it a case of generalized UHS □
Consider that S(τ), E(τ), I(τ), and R(τ) belong to
S′(τ)=∞∑j=1XjHj(τ),E′(τ)=∞∑j=1YjHj(τ),I′(τ)=∞∑j=1ZjHj(τ),R′(τ)=∞∑j=1WjHj(τ), |
where' denotes the derivative,
S(τ)=S0+K∑j=1XjPj,1(τ),E(τ)=E0+K∑j=1YjPj,1(τ),I(τ)=I0+K∑j=1ZjPj,1(τ),R(τ)=R0+K∑j=1WjPj,1(τ). | (5.1) |
Here, the operational matrix of integration is denoted by
1Γ(n−χ)∫τ0S(n)(λ)(τ−λ)n−χ−1dλ=Bχ−ηχS(τ)I(τ)−πχS(τ),1Γ(n−χ)∫τ0E(n)(λ)(τ−λ)n−χ−1dλ=ηχS(τ)I(τ)−(ωχ+πχ+Ωχ)I(τ),1Γ(n−χ)∫τ0I(n)(λ)(τ−λ)n−χ−1dλ=ΩE(τ)−(ρχ+πχ)I(τ),1Γ(n−χ)∫τ0R(n)(λ)(τ−λ)n−χ−1dλ=ρχI(τ)+ωχE(τ)−πχR(τ). |
Assuming χ to be within the range (0, 1), it follows that n = 1, and hence
1Γ(1−χ)∫τ0S′(λ)(τ−λ)−χdλ=Bχ−ηχS(τ)I(τ)−πχS(τ),1Γ(1−χ)∫τ0E′(λ)(τ−λ)−χdλ=ηχS(τ)I(τ)−(ωχ+πχ+Ωχ)I(τ),1Γ(1−χ)∫τ0I′(λ)(τ−λ)−χdλ=ΩχE(τ)−(ρχ+πχ)I(τ),1Γ(1−χ)∫τ0R′(λ)(τ−λ)−χdλ=ρχI(τ)+ωχE(τ)−πχR(τ). | (5.2) |
Next, from Haar approximations, the above becomes
1Γ(1−χ)∫τ0∞∑j=1XjHj(τ)(λ)(τ−λ)−χdλ=Bχ−ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))−πχ(S0+K∑j=1XjPj,1(τ)), |
1Γ(1−χ)∫τ0∞∑j=1YjHj(τ)(λ)(τ−λ)−χdλ=ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))−(ωχ+πχ+Ωχ)(I0+K∑j=1ZjPj,1(τ)), |
1Γ(1−χ)∫τ0∞∑j=1ZjHj(τ)(λ)(τ−λ)−χdλ=Ωχ(E0+K∑j=1YjPj,1(τ))−(ρχ+πχ)(I0+K∑j=1ZjPj,1(τ)), |
1Γ(1−χ)∫τ0∞∑j=1WjHj(τ)(λ)(τ−λ)−χdλ=ρχ(I0+K∑j=1ZjPj,1(τ))+ωχ(E0+K∑j=1YjPj,1(τ))−πχ(R0+K∑j=1WjPj,1(τ)). |
After some calculation we get
1Γ(1−χ)∫τ0∞∑j=1XjHj(τ)(t−λ)−χdλ+ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))+πχ(S0+K∑j=1XjPj,1(τ))=0, |
1Γ(1−χ)∫τ0∞∑j=1YjHj(τ)(τ−λ)−χdλ−ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))+(ωχ+πχ+Ωχ)(I0+K∑j=1ZjPj,1(τ))=0, |
1Γ(1−χ)∫τ0∞∑j=1ZjHj(τ)(τ−λ)−χdλ−Ωχ(E0+K∑j=1YjPj,1(τ))+(ρχ+πχ)(I0+K∑j=1ZjPj,1(τ))=0, |
1Γ(1−χ)∫τ0∞∑j=1WjHj(τ)(τ−λ)−χdλ−ρχ(I0+K∑j=1ZjPj,1(τ))−ωχ(E0+K∑j=1YjPj,1(τ))+πχ(R0+K∑j=1WjPj,1(τ))=0. |
Here, to approximate the integral in the prior system we have applied Haar's integration formula, as follows [35]:
∫yxf(τ)dτ≈y−xKK∑k=1f(τk)=K∑k=1f(x+(y−x)(k−0.5)K). |
Therefore, we obtain
τKΓ(1−χ)K∑n=1K∑j=1XjHj(λn)(τ−λn)−χ+ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))+πχ(S0+K∑j=1XjPj,1(τ))=0, |
and
τKΓ(1−χ)K∑n=1K∑j=1YjHj(λn)(τ−λn)−χ−ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))+(ωχ+πχ+Ωχ)(I0+K∑j=1ZjPj,1(τ))=0, |
and
τKΓ(1−χ)K∑n=1K∑j=1ZjHj(λn)(τ−λn)−χ−Ωχ(E0+K∑j=1YjPj,1(τ))+(ρχ+πχ)(I0+K∑j=1ZjPj,1(τ))=0, |
and
τKΓ(1−χ)K∑n=1K∑j=1WjHj(λn)(τ−λn)−χ−ρχ(I0+K∑j=1ZjPj,1(τ))−ωχ(E0+K∑j=1YjPj,1(τ))+πχ(R0+K∑j=1WjPj,1(τ))=0. |
Now, let
Θ1,i=tKΓ(1−χ)K∑n=1K∑j=1XjHj(λn)(τ−λn)−χ+ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))+πχ(S0+K∑j=1XjPj,1(τ)), |
and
Θ2,i=τKΓ(1−χ)K∑n=1K∑j=1YjHj(λn)(τ−λn)−χ−ηχ(S0+K∑j=1XjPj,1(τ))(I0+K∑j=1ZjPj,1(τ))+(ωχ+πχ+Ωχ)(I0+K∑j=1ZjPj,1(τ)), |
and
Θ3,i=τKΓ(1−χ)K∑n=1K∑j=1ZjHj(λn)(τ−λn)−χ−Ωχ(E0+K∑j=1YjPj,1(τ))+(ρχ+πχ)(I0+K∑j=1ZjPj,1(τ)), |
and
Θ4,i=τKΓ(1−χ)K∑n=1K∑j=1WjHj(λn)(τ−λn)−χ−ρχ(I0+K∑j=1ZjPj,1(τ))−ωχ(E0+K∑j=1YjPj,1(τ))+πχ(R0+K∑j=1WjPj,1(τ)). |
Combining the nodal points results in this nonlinear system yields
Θ1,i=τiKΓ(1−χ)K∑n=1K∑j=1XjHj(λn)(τi−λn)−χ+ηχ(S0+K∑j=1XjPj,1(τi))(I0+K∑j=1ZjPj,1(τi))+πχ(S0+K∑j=1XjPj,1(τi)), |
and
Θ2,i=τiKΓ(1−χ)K∑n=1K∑j=1YjHj(λn)(τi−λn)−χ−ηχ(S0+K∑j=1XjPj,1(τi))(I0+K∑j=1ZjPj,1(τi))+(ωχ+πχ+Ωχ)(I0+K∑j=1ZjPj,1(τi)), |
and
Θ3,i=τiKΓ(1−χ)K∑n=1K∑j=1ZjHj(λn)(τi−λn)−χ−Ωχ(E0+K∑j=1YjPj,1(τi))+(ρχ+πχ)(I0+K∑j=1ZjPj,1(τi)), |
and
Θ4,i=τiKΓ(1−χ)K∑n=1K∑j=1WjHj(λn)(τi−λn)−χ−ρχ(I0+K∑j=1ZjPj,1(τi))−ωχ(E0+K∑j=1YjPj,1(τi))+πχ(R0+K∑j=1WjPj,1(τi)). |
Utilizing Broyden's method, we can solve this system. The Jacobian matrix is expressed as follows:
The Jacobian matrix is determined by evaluating the following partial derivatives:
∂Θ1,i∂Xk,∂Θ1,i∂Yk,∂Θ1,i∂Zk,∂Θ1,i∂Wk,∂Θ2,i∂Xk,∂Θ2,i∂Yk,∂Θ2,i∂Zk,∂Θ2,i∂Wk,∂Θ3,i∂Xk,∂Θ3,i∂Yk,∂Θ3,i∂Zk,∂Θ3,i∂Wk,∂Θ4,i∂Xk,∂Θ4,i∂Yk,∂Θ4,i∂Zk,∂Θ4,i∂Wk. |
where
{∂Θ1,i∂Xk=τiKΓ(1−χ)K∑n=1hk(λn)(τi−λn)−χ+ηχ(I0Pk,1(τi)+Pk,1(τi)K∑j=1ZjPj,1(τi))+πχPk,1(τi)∂Θ1,i∂Yk=0∂Θ1,i∂Zk=ηχ(S0Pk,1(τi)+K∑j=1XjPj,1(τi)Pk,1(τi))∂Θ1,i∂Wk=0 |
and
{∂Θ2,i∂Xk=−ηχ(I0Pk,1(τi)+Pk,1(τi)K∑j=1ZjPj,1(τi))∂Θ2,i∂Yk=τiKΓ(1−χ)K∑n=1hk(λn)(τi−λn)−χ∂Θ2,i∂Zk=−ηχ(S0Pk,1(τi)+K∑j=1XjPj,1(τi)Pk,1(τi))+(ωχ+πχ+Ωχ)Pk,1(τi)∂Θ2,i∂Wk=0 |
and
{∂Θ3,i∂Xk=0∂Θ3,i∂Yk=−ΩχPk,1(τi)∂Θ3,i∂Zk=τiKΓ(1−χ)K∑n=1hk(λn)(τi−λn)−χ(ρχ+πχ)Pk,1(τi)∂Θ3,i∂Zk=0 |
and
{∂Θ4,i∂Xk=0∂Θ4,i∂Yk=−ωχPk,1(τi)∂Θ4,i∂Zk=ρχPk,1(τi)∂Θ4,i∂Wk=tiKΓ(1−χ)K∑n=1hk(λn)(τi−λn)−χ+πχPk,1(τi) |
The unknown coefficients
rρ(N)=1log2log(Maximum absolute error at N2Maximum absolute error at N). |
Next, we will present the graphical outcomes.
In this study, we employed the fractional SEIR model to visualize the dynamics of individuals in different states: susceptible, exposed, infected, and recovered. To ensure the reliability of our investigations, we conducted numerical simulations and graphical analyses for a range of χ values. To solve this model computationally, we utilized the HWCM. Specifically, we have considered the fractional SEIR model (2.3), where we have set the initial values as follows: S(0)=600, E(0)=250, I(0)=100, and R(0)=50. It is important to note that we have assumed a constant total population size (N). Additionally, we have defined the following parameter values for the numerical simulations and results: B=0.32,π=0.2,Ω=0.01,ρ=0.2,η=0.01, and ω=0.25 per day. The resulting figures, encompassing Figures 2 through 5, offer valuable insights into the behaviors of different groups, including susceptible, exposed, infected, and recovered people. Figure 6 displays the fractional-order derivatives of susceptible people for different values of the fractional parameter χ ranging from 0.75 to 1. It demonstrates a decreasing number of vulnerable people over time as a result of viral exposure, which is consistent with other epidemiological models. In Figure 7, we can observe a clear trend in the population of individuals who have been exposed, showing a consistent and rapid increase as the fractional derivative converges towards its classical solution. The rise can be attributed to an increased proportion of susceptible people being infected and moving into the exposed category. In Figure 8, we can observe an increase in the count of infected individuals as the fractional order approaches 1. This phenomenon is attributed to the heightened sensitivity of the fractional order to different values of the fractional parameter denoted as χ. Figure 9 depicts that as the fractional-order derivative approaches the classical value, we observe a consistent increase in the count of individuals who have successfully recovered, owing mostly to the recovery of infected individuals and thereby playing a significant role in the containment of the transmission of the disease. The population growth in the recovered category will accelerate with an increase in the fractional order. In Figure 10, we visualize the dynamics of the entire SEIR model (2.3) at χ=1. A more accurate representation of the data was made possible by the application of Haar wavelet collocation techniques, which has led to a more exact and trustworthy model. It is also to be emphasized that we have observed a high rate of infected population at the initial stage of infection, but after a certain time, the rate of increase of infected individuals density sloweed down. Further, we have observed that the recovery rate was slow at the initial stage but became high after a certain time. The comparative analysis between the susceptible, exposed, infected, and recovered individuals in the fractional SEIR model has been shown graphically for various values of fractional order. Graphical representations demonstrate how parameters and fractional orders affect the behaviors of susceptible, exposed, infected, and recovered individuals, providing valuable insights into population dynamics during disease outbreaks. This study emphasizes the necessity of employing modern techniques to gain a deeper understanding of the dynamics of the measles disease.
We have successfully applied the HWCM to solve fractional measles models efficiently. We investigated the application of fractional derivatives within the Caputo framework to analyze the dynamics of the measles epidemic model. Our method accounts for a number of variables that influence the spread of viruses, and the incorporation of fractional derivatives represents a major advancement in terms of accuracy and effectiveness. To efficiently handle these fractional derivatives, we made use of the Broyden methodology and the HWCM. The Ulam-Hyers method was helpful in determining the stability of the system and offered a vital perspective on the dependability of the model. The major contributions of this study are the application of the HWCM, our investigation of fractional derivatives in the Caputo framework, advancements in accuracy and effectiveness, and our impact on understanding population dynamics. We have shown how the parameters and fractional orders affect the behaviours of susceptible, exposed, infected, and recovered individuals through graphical representations of the dynamics within these compartments across a range of fractional order values. This study emphasizes the need to utilize modern techniques to acquire a greater understanding of the complexities of the measles outbreak. Consequently, the suggested approach is very efficient and applicable to many mathematical models, such as models of cancer treatment, drug targeting systems, and biotherapy. This methodology can be easily implemented in computer programs, and with a small modification to the existing approach, it may be extended to higher degrees. The study's finding suggests that the methodology is not only applicable to measles models but also to various other mathematical models, such as influenza, tuberculosis, or HIV/AIDS, for the analysis and prediction of disease spread dynamics.
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
[1] |
Y. Wang, Y. Zhang, P. Wang, X. Fu, W. Lin, Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy, Mol. Cancer, 19 (2020), 149. https://doi.org/10.1186/s12943-020-01266-7 doi: 10.1186/s12943-020-01266-7
![]() |
[2] |
H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71 (2021), 209–249. https://doi.org/10.3322/caac.21660 doi: 10.3322/caac.21660
![]() |
[3] |
M. He, F. Hu, TF-RBP-AS Triplet analysis reveals the mechanisms of aberrant alternative splicing events in kidney cancer: implications for their possible clinical use as prognostic and therapeutic biomarkers, Int. J. Mol. Sci., 22 (2021), 8789. https://doi.org/10.3390/ijms22168789 doi: 10.3390/ijms22168789
![]() |
[4] |
A. Znaor, J. Lortet-Tieulent, M. Laversanne, A. Jemal, F. Bray, International variations and trends in renal cell carcinoma incidence and mortality, Eur. Urol., 67 (2015), 519–530. https://doi.org/10.1016/j.eururo.2014.10.002 doi: 10.1016/j.eururo.2014.10.002
![]() |
[5] |
Z. Sun, C. Jing, X. Guo, M. Zhang, F. Kong, Z. Wang, et al., Comprehensive analysis of the immune infiltrates of pyroptosis in kidney renal clear cell carcinoma, Front. Oncol., 11 (2021), 716854. https://doi.org/10.3389/fonc.2021.716854 doi: 10.3389/fonc.2021.716854
![]() |
[6] |
X. Mao, J. Xu, W. Wang, C. Liang, J. Hua, J. Liu, et al., Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives, Mol. Cancer, 20 (2021), 131. https://doi.org/10.1186/s12943-021-01428-1 doi: 10.1186/s12943-021-01428-1
![]() |
[7] |
L. F. S. Patterson, S. A. Vardhana, Metabolic regulation of the cancer-immunity cycle, Trends Immunol., 42 (2021), 975–993. https://doi.org/10.1016/j.it.2021.09.002 doi: 10.1016/j.it.2021.09.002
![]() |
[8] |
Y. Senbabaoglu, R. S. Gejman, A. G. Winer, M. Liu, E. M. Van Allen, G. de Velasco, et al., Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures, Genome Biol., 17 (2016), 231. https://doi.org/10.1186/s13059-016-1092-z doi: 10.1186/s13059-016-1092-z
![]() |
[9] |
B. Wang, D. Chen, H. Hua, TBC1D3 family is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma, Mol. Ther. Oncolytics, 22 (2021), 528–538. https://doi.org/10.1016/j.omto.2021.06.014 doi: 10.1016/j.omto.2021.06.014
![]() |
[10] |
G. Liao, P. Wang, Y. Wang, Identification of the prognosis value and potential mechanism of immune checkpoints in renal clear cell carcinoma microenvironment, Front. Oncol., 11 (2021), 720125. https://doi.org/10.3389/fonc.2021.720125 doi: 10.3389/fonc.2021.720125
![]() |
[11] |
A. D. Janiszewska, S. Poletajew, A. Wasiutyński, Reviews Spontaneous regression of renal cell carcinoma, Współczesna Onkologia, 2 (2013), 123–127. https://doi.org/10.5114/wo.2013.34613 doi: 10.5114/wo.2013.34613
![]() |
[12] |
B. A. Inman, M. R. Harrison, D. J. George, Novel immunotherapeutic strategies in development for renal cell carcinoma, Eur, Urol, , 63 (2013), 881–889. https://doi.org/10.1016/j.eururo.2012.10.006 doi: 10.1016/j.eururo.2012.10.006
![]() |
[13] |
A. Kulkarni, M. T. Chang, J. H. A. Vissers, A. Dey, K. F. Harvey, The Hippo pathway as a driver of select human cancers, Trends Cancer, 6 (2020), 781–796. https://doi.org/10.1016/j.trecan.2020.04.004 doi: 10.1016/j.trecan.2020.04.004
![]() |
[14] |
Y. Zheng, D. Pan, The hippo signaling pathway in development and disease, Dev. Cell, 50 (2019), 264–282. https://doi.org/10.1016/j.devcel.2019.06.003 doi: 10.1016/j.devcel.2019.06.003
![]() |
[15] |
M. Moloudizargari, M. H. Asghari, S. F. Nabavi, D. Gulei, I. Berindan-Neagoe, A. Bishayee, et al., Targeting Hippo signaling pathway by phytochemicals in cancer therapy, Semin. Cancer Biol., 80 (2020), 183–194. https://doi.org/10.1016/j.semcancer.2020.05.005 doi: 10.1016/j.semcancer.2020.05.005
![]() |
[16] |
F. Reggiani, G. Gobbi, A. Ciarrocchi, V. Sancisi, YAP and TAZ are not identical twins, Trends Biochem. Sci., 46 (2021), 154–168. https://doi.org/10.1016/j.tibs.2020.08.012 doi: 10.1016/j.tibs.2020.08.012
![]() |
[17] |
H. Zhang, C. Y. Liu, Z. Y. Zha, B. Zhao, J. Yao, S. Zhao, et al., TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition, J. Biol. Chem., 284 (2009), 13355–13362. https://doi.org/10.1074/jbc.M900843200 doi: 10.1074/jbc.M900843200
![]() |
[18] |
B. Zhao, X. Ye, J. Yu, L. Li, W. Li, S. Li, et al., TEAD mediates YAP-dependent gene induction and growth control, Genes Dev., 22 (2008), 1962–1971. https://doi.org/10.1101/gad.1664408 doi: 10.1101/gad.1664408
![]() |
[19] |
M. Murakami, J. Tominaga, R. Makita, Y. Uchijima, Y. Kurihara, O. Nakagawa, et al., Transcriptional activity of Pax3 is co-activated by TAZ, Biochem. Biophys. Res. Commun., 339 (2006), 533–539. https://doi.org/10.1016/j.bbrc.2005.10.214 doi: 10.1016/j.bbrc.2005.10.214
![]() |
[20] |
Z. Miskolczi, M. P. Smith, E. J. Rowling, J. Ferguson, J. Barriuso, C. Wellbrock, et al., Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing, Oncogene, 37 (2018), 3166–3182. https://doi.org/10.1038/s41388-018-0209-0 doi: 10.1038/s41388-018-0209-0
![]() |
[21] |
M. Murakami, M. Nakagawa, E. Olson, O. Nakagawa, A WW domain protein TAZ is a critical coactivator for TBX5 a transcription factor implicated in Holt Oram syndrome, Proc. Natl. Acad. Sci., 102 (2005), 18034–18039. https://doi.org/10.1073/pnas.0509109102 doi: 10.1073/pnas.0509109102
![]() |
[22] |
J. Rosenbluh, D. Nijhawan, A. G. Cox, X. Li, J. T. Neal, E. J. Schafer, et al., beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis, Cell, 151 (2012), 1457–1473. https://doi.org/10.1016/j.cell.2012.11.026 doi: 10.1016/j.cell.2012.11.026
![]() |
[23] |
F. Zanconato, M. Forcato, G. Battilana, L. Azzolin, E. Quaranta, B. Bodega, et al., Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth, Nat. Cell Biol., 17 (2015), 1218–1227. https://doi.org/10.1038/ncb3216 doi: 10.1038/ncb3216
![]() |
[24] |
H. L. Li, Q. Y. Li, M. J. Jin, C. F. Lu, Z. Y. Mu, W. Y. Xu, et al., A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression, J. Cancer Res. Clin. Oncol., 147 (2021), 1569–1585. https://doi.org/10.1007/s00432-021-03604-8 doi: 10.1007/s00432-021-03604-8
![]() |
[25] |
G. D. Chiara, F. Gervasoni, M. Fakiola, C. Godano, C. D'Oria, L. Azzolin, et al., Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ, Nat. Commun., 12 (2021), 2340. https://doi.org/10.1038/s41467-021-22544-y doi: 10.1038/s41467-021-22544-y
![]() |
[26] |
Y. Wang, X. Xu, D. Maglic, M. T. Dill, K. Mojumdar, P. K. S. Ng, et al., Comprehensive molecular characterization of the hippo signaling pathway in cancer, Cell Rep., 25 (2018), 1304–1317. https://doi.org/10.1016/j.celrep.2018.10.001 doi: 10.1016/j.celrep.2018.10.001
![]() |
[27] |
W. H. Yang, C. K. C. Ding, T. Sun, G. Rupprecht, C. C. Lin, D. Hsu, et al., The hippo pathway effector taz regulates ferroptosis in renal cell carcinoma, Cell Rep., 28 (2019), 2501–2508. https://doi.org/10.1016/j.celrep.2019.07.107 doi: 10.1016/j.celrep.2019.07.107
![]() |
[28] |
W. H. Yang, Z. Huang, J. Wu, C. K. C. Ding, S. K. Murphy, J. T. Chi, A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer, Mol. Cancer Res., 18 (2020), 79–90. https://doi.org/10.1158/1541-7786.MCR-19-0691 doi: 10.1158/1541-7786.MCR-19-0691
![]() |
[29] |
W. H. Yang, C. C. Lin, J. Wu, P. Y. Chao, K. Chen, P. H. Chen, et al., The hippo pathway effector YAP promotes ferroptosis via the E3 Ligase SKP2, Mol. Cancer Res., 19 (2021), 1005–1014. https://doi.org/10.1158/1541-7786.MCR-20-0534 doi: 10.1158/1541-7786.MCR-20-0534
![]() |
[30] |
M. Pavel, M. Renna, S. J. Park, F. M. Menzies, T. Ricketts, J. Füllgrabe, et al., Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis, Nat. Commun., 9 (2018), 2961. https://doi.org/10.1038/s41467-018-05388-x doi: 10.1038/s41467-018-05388-x
![]() |
[31] |
M. Toth, L. Wehling, L. Thiess, F. Rose, J. Schmitt, S. M. Weiler, et al., Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma, BMC Cancer, 21 (2021), 1079. https://doi.org/10.1186/s12885-021-08794-5 doi: 10.1186/s12885-021-08794-5
![]() |
[32] |
S. M. White, M. L. Avantaggiati, I. Nemazanyy, C. Di Poto, Y. Yang, M. Pende, et al., YAP/TAZ inhibition induces metabolic and signaling rewiring resulting in targetable vulnerabilities in NF2-deficient tumor cells, Dev. Cell, 49 (2019), 425–443. https://doi.org/10.1016/j.devcel.2019.04.014 doi: 10.1016/j.devcel.2019.04.014
![]() |
[33] |
S. W. Zhang, N. Zhang, N. Wang, Role of COL3A1 and POSTN on pathologic stages of esophageal cancer, Technol. Cancer Res. Treat., 19 (2020), 1533033820977489. https://doi.org/10.1177/1533033820977489 doi: 10.1177/1533033820977489
![]() |
[34] |
D. Xu, Y. Xu, Y. Lv, F. Wu, Y. Liu, M. Zhu, et al., Identification of four pathological stage-relevant genes in association with progression and prognosis in clear cell renal cell carcinoma by integrated bioinformatics analysis, Biomed. Res. Int., 2020 (2020), 2137319. https://doi.org/10.1155/2020/2137319 doi: 10.1155/2020/2137319
![]() |
[35] |
S. Bai, L. Chen, Y. Yan, X. Wang, A. Jiang, R. Li, et al., Identification of hypoxia-immune-related gene signatures and construction of a prognostic model in kidney renal clear cell carcinoma, Front. Cell Dev. Biol., 9 (2021), 796156. https://doi.org/10.3389/fcell.2021.796156 doi: 10.3389/fcell.2021.796156
![]() |
[36] |
S. Sun, W. Mao, L. Wan, K. Pan, L. Deng, L. Zhang, et al., Metastatic immune-related genes for affecting prognosis and immune response in renal clear cell carcinoma, Front. Mol. Biosci., 8 (2021), 794326. https://doi.org/10.3389/fmolb.2021.794326 doi: 10.3389/fmolb.2021.794326
![]() |
[37] |
J. Jing, J. Sun, Y. Wu, N. Zhang, C. Liu, S. Chen, et al., AQP9 is a prognostic factor for kidney cancer and a promising indicator for M2 TAM polarization and CD8+ T-cell recruitment, Front. Oncol., 11 (2021), 770565. https://doi.org/10.3389/fonc.2021.770565 doi: 10.3389/fonc.2021.770565
![]() |
[38] |
J. Song, Y. D. Liu, J. Su, D. Yuan, F. Sun, J. Zhu, Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma, J. Cell Physiol., 234 (2019), 22753–22764. https://doi.org/10.1002/jcp.28840 doi: 10.1002/jcp.28840
![]() |
[39] |
G. Du, X. Yan, Z. Chen, R. J. Zhang, K. Tuoheti, X. J. Bai, et al., Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC), Aging (Albany NY), 12 (2020), 8484–8505. https://doi.org/10.18632/aging.103153 doi: 10.18632/aging.103153
![]() |
[40] |
G. Chen, Y. Wang, L. Wang, W. Xu, Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma, Oncotarget, 8 (2017), 5268–5280. https://doi.org/10.18632/oncotarget.14134 doi: 10.18632/oncotarget.14134
![]() |
[41] |
G. Lin, Q. Feng, F. Zhan, F. Yang, Y. Niu, G. Li, Generation and analysis of pyroptosis-based and immune-based signatures for kidney renal clear cell carcinoma patients, and cell experiment, Front. Genet., 13 (2022), 809794. https://doi.org/10.3389/fgene.2022.809794 doi: 10.3389/fgene.2022.809794
![]() |
[42] |
X. L. Xing, Y. Liu, J. Liu, H. Zhou, H. Zhang, Q. Zuo, et al., Comprehensive analysis of ferroptosis- and immune-related signatures to improve the prognosis and diagnosis of kidney renal clear cell carcinoma, Front. Immunol., 13 (2022), 851312. https://doi.org/10.3389/fimmu.2022.851312 doi: 10.3389/fimmu.2022.851312
![]() |
[43] |
Y. Hong, M. Lin, D. Ou, Z. Huang, P. Shen, A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma, BMC Cancer, 21 (2021), 831. https://doi.org/10.1186/s12885-021-08559-0 doi: 10.1186/s12885-021-08559-0
![]() |
[44] |
Y. Zhang, M. Tang, Q. Guo, H. Xu, Z. Yang, D. Li, The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis, Gene, 816 (2022), 146173. https://doi.org/10.1016/j.gene.2021.146173 doi: 10.1016/j.gene.2021.146173
![]() |
[45] |
Y. L. Wang, H. Liu, L. L. Wan, K. H. Pan, J. X. Ni, Q. Hu, et al., Characterization and function of biomarkers in sunitinib-resistant renal carcinoma cells, Gene, 832 (2022), 146514. https://doi.org/10.1016/j.gene.2022.146514 doi: 10.1016/j.gene.2022.146514
![]() |
[46] |
X. Che, X. Qi, Y. Xu, Q. Wang, G. Wu, Using genomic and transcriptome analyses to identify the role of the oxidative stress pathway in renal clear cell carcinoma and its potential therapeutic significance, Oxid. Med. Cell Longev., 2021 (2021), 5561124. https://doi.org/10.1155/2021/5561124 doi: 10.1155/2021/5561124
![]() |
[47] |
X. Che, X. Qi, Y. Xu, Q. Wang, G. Wu, Genomic and transcriptome analysis to identify the role of the mtor pathway in kidney renal clear cell carcinoma and its potential therapeutic significance, Oxid. Med. Cell Longev., 2021 (2021), 6613151. https://doi.org/10.1155/2021/6613151 doi: 10.1155/2021/6613151
![]() |
[48] |
G. Tan, Z. Xuan, Z. Li, S. Huang, G. Chen, Y. Wu, et al., The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma, Transl. Androl. Urol., 9 (2020), 1725–1734. https://doi.org/10.21037/tau-20-1079 doi: 10.21037/tau-20-1079
![]() |
[49] |
M. Huang, T. Zhang, Z. Y. Yao, C. Xing, Q. Wu, Y. W. Liu, et al., MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma, BMC Med. Genomics, 14 (2021), 72. https://doi.org/10.1186/s12920-021-00932-z doi: 10.1186/s12920-021-00932-z
![]() |
[50] |
L. Peng, Z. Chen, Y. Chen, X. Wang, N. Tang, MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers, Cancer Med., 8 (2019), 7161–7173. https://doi.org/10.1002/cam4.2583 doi: 10.1002/cam4.2583
![]() |
[51] |
D. Zhang, S. Zeng, X. Hu, Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma, Cancer Cell Int., 20 (2020), 319. https://doi.org/10.1186/s12935-020-01423-4 doi: 10.1186/s12935-020-01423-4
![]() |
[52] |
S. Khadirnaikar, P. Kumar, S. N. Pandi, R. Malik, S. M. Dhanasekaran, S. K. Shukla, Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma, Mol. Carcinog., 58 (2019), 544–553. https://doi.org/10.1002/mc.22949 doi: 10.1002/mc.22949
![]() |
[53] |
E. Clough, T. Barrett, The gene expression omnibus database, Methods Mol. Biol., 1418 (2016), 93–110. https://doi.org/10.1007/978-1-4939-3578-9_5 doi: 10.1007/978-1-4939-3578-9_5
![]() |
[54] |
M. E. Ritchie, B. Phipson, D. I. Wu, Y. Hu, C. W. Law, W. Shi, et al., Limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res., 43 (2015), e47. https://doi.org/10.1093/nar/gkv007 doi: 10.1093/nar/gkv007
![]() |
[55] |
Z. Jiang, M. Shao, X. Dai, Z. Pan, D. Liu, Identification of diagnostic biomarkers in systemic lupus erythematosus based on bioinformatics analysis and machine learning, Front. Genet., 13 (2022), 865559. https://doi.org/10.3389/fgene.2022.865559 doi: 10.3389/fgene.2022.865559
![]() |
[56] |
T. Wu, E. Hu, S. Xu, M. Chen, P. Guo, Z. Dai, et al., clusterProfiler 4.0: A universal enrichment tool for interpreting omics data, Innovation, 2 (2021), 100141. https://doi.org/10.1016/j.xinn.2021.100141 doi: 10.1016/j.xinn.2021.100141
![]() |
[57] |
Gene Ontology Consortium, The Gene Ontology (GO) database and informatics resource, Nucleic Acids Res., 32 (2004), D258–D261. https://doi.org/10.1093/nar/gkh036 doi: 10.1093/nar/gkh036
![]() |
[58] |
D. Szklarczyk, A. L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, et al., STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic Acids Res., 47 (2019), D607–D613. https://doi.org/10.1093/nar/gky1131 doi: 10.1093/nar/gky1131
![]() |
[59] |
P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res., 13 (2003), 2498–2504. https://doi.org/10.1101/gr.1239303 doi: 10.1101/gr.1239303
![]() |
[60] |
W. Lin, Y. Tang, M. Zhang, B. Liang, M. Wang, L. Zha, et al., Integrated bioinformatic analysis reveals txnrd1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension, Front. Med., 9 (2022), 894584. https://doi.org/10.3389/fmed.2022.894584 doi: 10.3389/fmed.2022.894584
![]() |
[61] |
A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, et al., Gene set enrichment analysis A knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci., 102 (2005), 15545–15550. https://doi.org/10.1073/pnas.0506580102 doi: 10.1073/pnas.0506580102
![]() |
[62] |
Z. Zhuang, D. Li, M. Jiang, Y. Wang, Q. Cao, S. Li, et al., An integrative bioinformatics analysis of the potential mechanisms involved in propofol affecting hippocampal neuronal cells, Comput. Intell. Neurosci., 2022 (2022), 4911773. https://doi.org/10.1155/2022/4911773 doi: 10.1155/2022/4911773
![]() |
[63] |
F. Ponten, K. Jirstrom, M. Uhlen, The Human Protein Atlas--a tool for pathology, J. Pathol., 216 (2008), 387–393. https://doi.org/10.1002/path.2440 doi: 10.1002/path.2440
![]() |
[64] |
D. S. Chandrashekar, B. Bashel, S. A. H. Balasubramanya, C. J. Creighton, I. Ponce-Rodriguez, B. V. Chakravarthi, et al., UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia, 19 (2017), 649–658. https://doi.org/10.1016/j.neo.2017.05.002 doi: 10.1016/j.neo.2017.05.002
![]() |
[65] |
Z. Tang, C. Li, B. Kang, G. Gao, C. Li, Z. Zhang, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Res., 45 (2017), W98–W102. https://doi.org/10.1093/nar/gkx247 doi: 10.1093/nar/gkx247
![]() |
[66] |
Y. C. Yang, M. Y. Zhang, J. Y. Liu, Y. Y. Jiang, X. L. Ji, Y. Q. Qu, Identification of ferroptosis-related hub genes and their association with immune infiltration in chronic obstructive pulmonary disease by bioinformatics analysis, Int. J. Chron. Obstruct. Pulmon. Dis., 17 (2022), 1219–1236. https://doi.org/10.2147/COPD.S348569 doi: 10.2147/COPD.S348569
![]() |
[67] |
T. Li, J. Fu, Z. Zeng, D. Cohen, J. Li, Q. Chen, et al., TIMER2.0 for analysis of tumor-infiltrating immune cells, Nucleic Acids Res, 48 (2020), W509–W514. https://doi.org/10.1093/nar/gkaa407 doi: 10.1093/nar/gkaa407
![]() |
[68] |
B. A. Teicher, TGFbeta-directed therapeutics: 2020, Pharmacol. Ther., 217 (2021), 107666. https://doi.org/10.1016/j.pharmthera.2020.107666 doi: 10.1016/j.pharmthera.2020.107666
![]() |
[69] |
A. E. Vilgelm, A. Richmond, Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy, Front. Immunol., 10 (2019), 333. https://doi.org/10.3389/fimmu.2019.00333 doi: 10.3389/fimmu.2019.00333
![]() |
[70] |
R. Wang, B. Zheng, H. Liu, X. Wan, Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539, Cell Cycle, 19 (2020), 1122–1131. https://doi.org/10.1080/15384101.2020.1748949 doi: 10.1080/15384101.2020.1748949
![]() |
[71] |
S. Nagashima, J. Maruyama, K. Honda, Y. Kondoh, H. Osada, M. Nawa, et al., CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells, J. Biol. Chem., 297 (2021), 100803. https://doi.org/10.1016/j.jbc.2021.100803 doi: 10.1016/j.jbc.2021.100803
![]() |
[72] |
P. Chen, Y. Duan, X. Lu, L. Chen, W. Zhang, H. Wang, et al., RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation, Cancer Immunol. Immunother., 70 (2021), 3261–3275. https://doi.org/10.1007/s00262-021-02913-8 doi: 10.1007/s00262-021-02913-8
![]() |
[73] |
S. Xu, H. Zhang, Y. Chong, B. Guan, P. Guo, YAP promotes VEGFA expression and tumor angiogenesis though Gli2 in human renal cell carcinoma, Arch. Med. Res., 50 (2019), 225–233. https://doi.org/10.1016/j.arcmed.2019.08.010 doi: 10.1016/j.arcmed.2019.08.010
![]() |
[74] |
P. Carter, U. Schnell, C. Chaney, B. Tong, X. Pan, J. Ye, et al., Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma, J. Clin. Invest., 131 (2021), e144108. https://doi.org/10.1172/JCI144108 doi: 10.1172/JCI144108
![]() |
[75] |
S. Xu, H. Zhang, T. Liu, Z. Wang, W. Yang, T. Hou, et al., 6-Gingerol suppresses tumor cell metastasis by increasing YAP(ser127) phosphorylation in renal cell carcinoma, J. Biochem. Mol. Toxicol., 35 (2021), e22609. https://doi.org/10.1002/jbt.22609 doi: 10.1002/jbt.22609
![]() |
[76] |
S. Xu, Z. Yang, Y. Fan, B. Guan, J. Jia, Y. Gao, et al., Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53, Oncol. Lett., 12 (2016), 4999–5006. https://doi.org/10.3892/ol.2016.5376 doi: 10.3892/ol.2016.5376
![]() |
[77] |
M. D. Robinson, D. J. McCarthy, G. K. Smyth, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26 (2010), 139–140. https://doi.org/10.1093/bioinformatics/btp616 doi: 10.1093/bioinformatics/btp616
![]() |
[78] |
S. Anders, W. Huber, Differential expression analysis for sequence count data, Genome Biol, , 11 (2010), R106. https://doi.org/10.1186/gb-2010-11-10-r106 doi: 10.1186/gb-2010-11-10-r106
![]() |
[79] |
M. I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15 (2014), 550. https://doi.org/10.1186/s13059-014-0550-8 doi: 10.1186/s13059-014-0550-8
![]() |
[80] |
D. W. Huang, B. T. Sherman, R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc., 4 (2009), 44–57. https://doi.org/10.1038/nprot.2008.211 doi: 10.1038/nprot.2008.211
![]() |
[81] |
C. Xie, X. Mao, J. Huang, Y. Ding, J. Wu, S. Dong, et al., KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases, Nucleic Acids Res., 39 (2011), W316–W322. https://doi.org/10.1093/nar/gkr483 doi: 10.1093/nar/gkr483
![]() |
[82] |
Y. Zhou, B. Zhou, L. Pache, M. Chang, A. H. Khodabakhshi, O. Tanaseichuk, et al., Metascape provides a biologist-oriented resource for the analysis of systems-level datasets, Nat. Commun., 10 (2019), 1523. https://doi.org/10.1038/s41467-019-09234-6 doi: 10.1038/s41467-019-09234-6
![]() |
[83] |
Y. Liao, J. Wang, E. J. Jaehnig, Z. Shi, B. Zhang, WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs, Nucleic Acids Res., 47 (2019), W199–W205. https://doi.org/10.1093/nar/gkz401 doi: 10.1093/nar/gkz401
![]() |
[84] |
M. D. Paraskevopoulou, G. Georgakilas, N. Kostoulas, M. Reczko, M. Maragkakis, T. M. Dalamagas, et al., DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs, Nucleic Acids Res., 41 (2013), D239–D245. https://doi.org/10.1093/nar/gks1246 doi: 10.1093/nar/gks1246
![]() |
[85] |
S. D. Hsu, F. M. Lin, W. Y. Wu, C. Liang, W. C. Huang, W. L. Chan, et al., miRTarBase: a database curates experimentally validated microRNA–target interactions, Nucleic Acids Res., 39 (2011), D163–D169. https://doi.org/10.1093/nar/gkq1107 doi: 10.1093/nar/gkq1107
![]() |
[86] |
J. H. Yang, J. H. Li, P. Shao, H. Zhou, Y. Q. Chen, starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data, Nucleic Acids Res., 39 (2011), D202–D209. https://doi.org/10.1093/nar/gkq1056 doi: 10.1093/nar/gkq1056
![]() |
[87] |
W. Liu, Y. Jiang, L. Peng, X. Sun, W. Gan, Q. Zhao, et al., Inferring gene regulatory networks using the improved markov blanket discovery algorithm, Interdiscip. Sci., 14 (2022), 168–181. https://doi.org/10.1007/s12539-021-00478-9 doi: 10.1007/s12539-021-00478-9
![]() |
[88] |
L. Zhang, P. Yang, H. Feng, Q. Zhao, H. Liu, Using Network Distance Analysis to Predict lncRNA-miRNA Interactions, Interdiscip. Sci., 13 (2021), 535–545. https://doi.org/10.1007/s12539-021-00458-z doi: 10.1007/s12539-021-00458-z
![]() |
[89] |
H. Liu, G. Ren, H. Chen, Q. Liu, Y. Yang, Q. Zhao, Predicting lncRNA–miRNA interactions based on logistic matrix factorization with neighborhood regularized, Knowledge Based Syst., 191 (2020), 105261. https://doi.org/10.1016/j.knosys.2019.105261 doi: 10.1016/j.knosys.2019.105261
![]() |
[90] |
W. Liu, H. Lin, L. Huang, L. Peng, T. Tang, Q. Zhao, et al., Identification of miRNA-disease associations via deep forest ensemble learning based on autoencoder, Brief Bioinform., 23 (2022), bbac104. https://doi.org/10.1093/bib/bbac104 doi: 10.1093/bib/bbac104
![]() |
[91] |
C. C. Wang, C. D. Han, Q. Zhao, X. Chen, Circular RNAs and complex diseases: from experimental results to computational models, Brief Bioinform., 22 (2021), bbab286. https://doi.org/10.1093/bib/bbab286 doi: 10.1093/bib/bbab286
![]() |
[92] |
A. Reustle, M. Di Marco, C. Meyerhoff, A. Nelde, J. S. Walz, S. Winter, et al., Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy, Genome Med., 12 (2020), 32. https://doi.org/10.1186/s13073-020-00731-8 doi: 10.1186/s13073-020-00731-8
![]() |
[93] |
K. Dong, W. Chen, X. Pan, H. Wang, Y. Sun, C. Qian, et al., FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity, BMC Cancer, 22 (2022), 140. https://doi.org/10.1186/s12885-022-09251-7 doi: 10.1186/s12885-022-09251-7
![]() |
[94] |
Y. Chen, F. He, R. Wang, M. Yao, Y. Li, D. Guo, et al., NCF1/2/4 are prognostic biomarkers related to the immune infiltration of kidney renal clear cell carcinoma, Biomed. Res. Int., 2021 (2021), 5954036. https://doi.org/10.1155/2021/5954036 doi: 10.1155/2021/5954036
![]() |
[95] |
B. G. Kim, E. Malek, S. H. Choi, J. J. Ignatz-Hoover, J. J. Driscoll, Novel therapies emerging in oncology to target the TGF-beta pathway, J. Hematol. Oncol., 14 (2021), 55. https://doi.org/10.1186/s13045-021-01053-x doi: 10.1186/s13045-021-01053-x
![]() |
[96] |
J. D. Richter, X. Zhao, The molecular biology of FMRP: new insights into fragile X syndrome, Nat. Rev. Neurosci., 22 (2021), 209–222. https://doi.org/10.1038/s41583-021-00432-0 doi: 10.1038/s41583-021-00432-0
![]() |
[97] |
Y. Laitman, L. Ries-Levavi, M. Berkensdadt, J. Korach, T. Perri, E. Pras, et al., FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patterns, Genet. Res., 96 (2014), e11. https://doi.org/10.1017/S0016672314000147 doi: 10.1017/S0016672314000147
![]() |
[98] |
W. Li, L. Zhang, B. Guo, J. Deng, S. Wu, F. Li, et al., Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFkappaB/c-Myc signaling in female esophageal carcinoma, Mol. Cancer, 18 (2019), 22. https://doi.org/10.1186/s12943-019-0949-7 doi: 10.1186/s12943-019-0949-7
![]() |
[99] |
Y. Jiang, Z. Wang, C. Ying, J. Hu, T. Zeng, L. Gao, FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs, Oncogene, 40 (2021), 4094–4110. https://doi.org/10.1038/s41388-021-01833-2 doi: 10.1038/s41388-021-01833-2
![]() |
[100] |
Z. Shen, B. Liu, B. Wu, H. Zhou, X. Wang, J. Cao, et al., FMRP regulates STAT3 mRNA localization to cellular protrusions and local translation to promote hepatocellular carcinoma metastasis, Commun. Biol., 4 (2021), 540. https://doi.org/10.1038/s42003-021-02071-8 doi: 10.1038/s42003-021-02071-8
![]() |
[101] |
Y. Higuchi, M. Ando, A. Yoshimura, S. Hakotani, Y. Koba, Y. Sakiyama, et al., Prevalence of fragile X-associated tremor/ataxia syndrome in patients with cerebellar ataxia in Japan, Cerebellum, (2021), 1–10. https://doi.org/10.1007/s12311-021-01323-x doi: 10.1007/s12311-021-01323-x
![]() |
[102] |
K. H. Yu, N. Palmer, K. Fox, L. Prock, K. D. Mandl, I. S. Kohane, et al., The phenotypical implications of immune dysregulation in fragile X syndrome, Eur. J. Neurol., 27 (2020), 590–593. https://doi.org/10.1111/ene.14146 doi: 10.1111/ene.14146
![]() |
[103] |
M. Careaga, D. Rose, F. Tassone, R. F. Berman, R. Hagerman, P. Ashwood, Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses, PLoS One, 9 (2014), e94475. https://doi.org/10.1371/journal.pone.0094475 doi: 10.1371/journal.pone.0094475
![]() |
[104] |
S. L. Hodges, S. O. Nolan, L. A. Tomac, I. D. Muhammad, M. S. Binder, J. H. Taube, et al., Lipopolysaccharide-induced inflammation leads to acute elevations in pro-inflammatory cytokine expression in a mouse model of Fragile X syndrome, Physiol. Behav., 215 (2020), 112776. https://doi.org/10.1016/j.physbeh.2019.112776 doi: 10.1016/j.physbeh.2019.112776
![]() |
[105] |
S. L. Hodges, S. O. Nolan, J. H. Taube, J. N. Lugo, Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-alpha expression, Neuroreport, 28 (2017), 1246–1249. https://doi.org/10.1097/WNR.0000000000000905 doi: 10.1097/WNR.0000000000000905
![]() |
1. | Mahboubeh Molavi-Arabshahi, Jalil Rashidinia, Mahnaz Yousefi, A novel hybrid method with convergence analysis for approximation of HTLV-I dynamics model, 2024, 14, 2045-2322, 10.1038/s41598-024-76110-9 | |
2. | Olumuyiwa James Peter, Modelling measles transmission dynamics and the impact of control strategies on outbreak Management, 2025, 19, 1751-3758, 10.1080/17513758.2025.2479448 |
Parameter | Description |
B | Birth rate |
ρ | Rate of recovery from infection |
η | Rate of infected individuals |
π | Natural death rate |
Ω | Infected rate |
ω | Measles therapy rate |